Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

All three treatments reduce hirsutism, but spironolactone works best long-term.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

DHT, a testosterone byproduct, causes male pattern baldness.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

High testosterone to epitestosterone ratio in hair could predict male-pattern baldness.

Quercetin may help with PCOS symptoms, but more research is needed.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

New sulfur-containing steroid analogs show promise for more targeted medical treatments.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Birth control pills and cyproterone acetate can help treat acne in women, especially when linked to hormonal issues.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.